{"id":"W4310275920","doi":"10.1007/s13555-022-00853-4","title":"Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program","year":2022,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada); SKiN Health; Memorial University of Newfoundland","funders":"Eli Lilly Canada; Eli Lilly and Company","keywords":"Ixekizumab; Plaque psoriasis; Persistence (discontinuity); Medicine; Psoriasis; Physical therapy; Dermatology; Psoriatic arthritis; Engineering; Secukinumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006691833,0.0001529033,0.0002652126,0.0005867603,0.00149214,0.0006204025,0.0005991143,0.000242973,0.002085383],"category_scores_gemma":[0.002281993,0.00012741,0.0002988572,0.001934802,0.0002500218,0.0002361631,0.0003218956,0.0005699114,0.0001172324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005909108,"about_ca_system_score_gemma":0.009894134,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.815883,"about_ca_topic_score_gemma":0.85769,"domain_scores_codex":[0.9991172,0.00006841149,0.00005922158,0.0001261242,0.0004247493,0.000204329],"domain_scores_gemma":[0.9985058,0.000107252,0.000726561,0.00003858403,0.0003186764,0.0003030979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009345404,0.00004493769,0.9943826,0.00004669937,0.00002994794,0.00004146828,0.0001499562,0.00003086505,0.00006680738,0.0000302586,0.0007358213,0.004347181],"study_design_scores_gemma":[0.00001116405,0.00005491485,0.9986144,0.00004383383,0.0000208265,0.0001246965,0.000272188,0.0001234376,0.00002642524,0.00001038024,0.0006937034,0.000004051035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931014,0.0009099205,0.00007197462,0.0002869126,0.000007864828,0.00007584244,0.003607945,0.000006789055,0.001931468],"genre_scores_gemma":[0.997726,0.0004248438,0.0001254478,0.0001083991,0.000009615531,0.00002628649,0.001397359,0.000001214823,0.0001808113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.184117,"threshold_uncertainty_score":0.3704026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02245852899902205,"score_gpt":0.2391384421415881,"score_spread":0.216679913142566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}